Pregled bibliografske jedinice broj: 1184806
Tumor immunotherapy side effects – early recognition and management
Tumor immunotherapy side effects – early recognition and management // Libri Oncologici : Croatian Journal of Oncology, 45 (2017), 2-3; 78-80 (recenziran, pregledni rad, znanstveni)
CROSBI ID: 1184806 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Tumor immunotherapy side effects – early recognition
and management
Autori
Pavlović Ružić, Ira ; Zahirović, Dag ; Pavlović, Sanja ; Belac Lovasić, Ingrid
Izvornik
Libri Oncologici : Croatian Journal of Oncology (2584-3826) 45
(2017), 2-3;
78-80
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
tumor immunotherapy ; side effects ; management of side effects ; checkpoint inhibitors ; anti-CTLA-4 immunotherapy
Sažetak
Implementation of immunotherapy in many cancer types has achieved positive results in tumor control and cure. The concept of immunotherapy is diff erent in comparison with conventional tumor therapies. While chemotherapy, hormonal or biological therapies target tumor cells and mechanisms, immunotherapy targets host immune system. Amplifi cation of defending possibilities or unblocking the control of the immune reactions are used. Besides positive results in tumor control, enhancing immunogenicity can provoke harm to other tissues and systems in form of adverse reactions or unwanted side effects of therapy. Early recognition of side effects is of crucial importance and prompt care can diminish the harm and severity. Knowledge about side effects is needed, therefore good education of all medical personnel included in treatment as well as patient education must be assured prior and thorough the treatment. Writt en guidelines are provided and easy reachable and must be used.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka